SCHEMBL18156791

SCHEMBL18156791

Brc1cccc2c1-c1ccccc1C21c2ccccc2-c2ccc3c(c21)-c1ccccc1C3

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 2/20 0.41
HTR2B P41595 2/20 0.35
KDM4E B2RXH2 1/20 0.34
NPC1 O15118 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
POLB P06746 1/20 0.32
MAOA P21397 1/20 0.32
DRD2 P14416 2/20 0.32
DRD4 P21917 1/20 0.32
DRD3 P35462 1/20 0.32
SRD5A2 P31213 1/20 0.31
ADRA1D P25100 1/20 0.30
HTR2A P28223 1/20 0.30
HTR2C P28335 1/20 0.30
HTR7 P34969 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18156793 0.86 PDK2 (0.43) PDK2HTR2BKDM4ENPC1ALDH1A1
SCHEMBL18156802 0.85 PDK2 (0.40) PDK2HTR2BKDM4ENPC1ALDH1A1
SCHEMBL18156799 0.80 PDK2 (0.40) PDK2HTR2BKDM4ENPC1ALDH1A1
SCHEMBL18156797 0.80 PDK2 (0.40) PDK2HTR2BKDM4ENPC1ALDH1A1
SCHEMBL29484645 0.78 PDK2 (0.56) PDK2KDM4EALDH1A1LMNAMAPT
SCHEMBL10053123 0.78 PDK2 (0.56) PDK2KDM4EALDH1A1LMNAMAPT
SCHEMBL18156788 0.78 PDK2 (0.38) PDK2HTR2BKDM4ENPC1ALDH1A1
SCHEMBL18156789 0.78 PDK2 (0.41) PDK2HTR2BKDM4ENPC1ALDH1A1
SCHEMBL18156792 0.78 PDK2 (0.48) PDK2HTR2BKDM4ENPC1ALDH1A1
SCHEMBL18160253 0.77 PDK2 (0.49) PDK2KDM4EALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2023-04-27 US disclosed
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS MERCK PATENT GMBH (DE) 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160308147-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 PDK2 264/4885HTR2B 2447/4885KDM4E 4246/4885
US-20230126850-A1 HETEROCYCLIC SPIRO COMPOUNDS NES, KCNC1, HCN4 PDK2 264/4885HTR2B 2447/4885KDM4E 4246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.